Tolerogenic and pathologic interactions between ILCs and T cells in autoimmunity
自身免疫中 ILC 和 T 细胞之间的耐受性和病理性相互作用
基本信息
- 批准号:10231152
- 负责人:
- 金额:$ 3.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-06 至 2022-02-25
- 项目状态:已结题
- 来源:
- 关键词:Active ImmunizationAdoptive TransferAffectAnatomyAnimal ModelAnti-Inflammatory AgentsAntigen PresentationAntigen-Presenting CellsAntigensApoptosisAutoantigensAutoimmuneAutoimmune DiseasesAutoimmunityCD4 Positive T LymphocytesCD80 geneCD86 geneCell CommunicationCell CountCellsCentral Nervous System DiseasesChronicClinicalComplexDataDiseaseEconomic BurdenEnvironmental Risk FactorExperimental Autoimmune EncephalomyelitisGene Expression ProfileGeneticGenetic ModelsHistocompatibility Antigens Class IIHumanImmuneImmune responseIncidenceIndividualInfectionInflammationInflammatoryInflammatory Bowel DiseasesInnate Immune SystemInterleukin-17IntestinesLaboratoriesLeadLife StyleLocationLymphoid CellMediatingMultiple SclerosisMusMyelinNeoplasmsNeuraxisPathogenesisPathogenicityPathologicPathway interactionsPeptidesPeripheralPhysiologic pulsePlayPredispositionPreventionPublic HealthPublicationsResearch ProposalsRheumatoid ArthritisRoleT cell responseT-LymphocyteTestingTherapeuticTissuesautoreactivitycell typechronic inflammatory diseasecommensal bacteriadifferential expressionexperimental studygain of functionin vivoinflammatory disease of the intestinelifestyle factorsloss of functionlymph nodesmicroorganismmouse modelneuropathologynovelpreventresponseside effectsystemic autoimmune disease
项目摘要
PROJECT SUMMARY
Autoimmunity and chronic inflammatory diseases develop as a result of a complex interplay of genetic,
environmental, and lifestyle factors that are unique to each individual. However, these diseases manifest in a
common immunologic response defined by a persistent hyper-responsiveness to self-tissues, environmental
antigens, or commensal microorganisms. Notably, recent genetic and experimental evidence demonstrate that
IL-17 producing CD4 T helper (Th17) cells are a major pathogenic cell type involved in the pathogenesis of
inflammatory bowel disease (IBD), multiple sclerosis (MS), and rheumatoid arthritis (RA). Despite these
advances, it remains poorly understood how Th17 cells are induced and regulated in the context of
autoimmunity. Recently my host laboratory defined that a related cell type of the innate immune system,
termed group 3 innate lymphoid cells (ILC3), play an essential tolerogenic role in the intestine by restraining
Th17 cell responses to commensal bacteria through antigen-presentation via major histocompatibility complex
class II (MHCII+ ILC3). In new preliminary data generated for this proposal, I now define that MHCII+ ILC3
functionally impact the progression of experimental autoimmune encephalomyelitis (EAE), an animal model for
T-cell mediated human multiple sclerosis (MS), and further test whether we can employ this tolerogenic
pathway to prevent EAE. The fundamental focus of this research proposal is to better define how ILC3/T cell
interactions occur and functionally impact the progression of autoimmunity to self-antigens. It is expected that
results from the two aims of this proposal will crucially define the role and therapeutic potential of modulating
interactions between ILC3s and CD4 T cells in the context of MS that could be extended to other forms of T
cell mediated autoimmunity.
项目摘要
自身免疫性和慢性炎症性疾病由于遗传的复杂相互作用而出现
每个人独有的环境和生活方式因素。但是,这些疾病表现在
常见的免疫反应由对自我组织的持续性超反应来定义
抗原或共生微生物。值得注意的是,最近的遗传和实验证据表明
IL-17产生CD4 T辅助器(TH17)细胞是参与参与的主要致病细胞类型
炎症性肠病(IBD),多发性硬化症(MS)和类风湿关节炎(RA)。尽管如此
进步,它仍然很了解如何在
自身免疫性。最近,我的宿主实验室定义了先天免疫系统的相关细胞类型,
称为3组先天淋巴样细胞(ILC3),通过限制在肠中起着重要的耐受作用
Th17细胞通过主要组织相容性复合物通过抗原呈递对共生细菌的反应
II类(MHCII+ ILC3)。在该提案生成的新初步数据中,我现在定义MHCII+ ILC3
在功能上影响实验自身免疫性脑脊髓炎(EAE)的进展,一种动物模型
T细胞介导的人类多发性硬化症(MS),并进一步测试我们是否可以采用这种耐受性
防止EAE的途径。该研究建议的基本重点是更好地定义ILC3/T细胞的方式
发生相互作用并在功能上影响自身免疫对自我抗原的发展。预计
该提案的两个目标的结果将至关重要地定义调节的作用和治疗潜力
在MS的背景下,ILC3S和CD4 T细胞之间的相互作用可以扩展到其他形式的T
细胞介导的自身免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Benjamin Grigg其他文献
John Benjamin Grigg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Benjamin Grigg', 18)}}的其他基金
Tolerogenic and pathologic interactions between ILCs and T cells in autoimmunity
自身免疫中 ILC 和 T 细胞之间的耐受性和病理性相互作用
- 批准号:
10017643 - 财政年份:2019
- 资助金额:
$ 3.08万 - 项目类别:
相似海外基金
Tolerogenic and pathologic interactions between ILCs and T cells in autoimmunity
自身免疫中 ILC 和 T 细胞之间的耐受性和病理性相互作用
- 批准号:
10017643 - 财政年份:2019
- 资助金额:
$ 3.08万 - 项目类别:
Autoimmunity in the Mediation of Infectious Myocarditis
自身免疫介导感染性心肌炎
- 批准号:
8853940 - 财政年份:2013
- 资助金额:
$ 3.08万 - 项目类别:
Autoimmunity in the Mediation of Infectious Myocarditis
自身免疫介导感染性心肌炎
- 批准号:
8721481 - 财政年份:2013
- 资助金额:
$ 3.08万 - 项目类别:
Autoimmunity in the Mediation of Infectious Myocarditis
自身免疫介导感染性心肌炎
- 批准号:
9069029 - 财政年份:2013
- 资助金额:
$ 3.08万 - 项目类别:
Autoimmunity in the Mediation of Infectious Myocarditis
自身免疫介导感染性心肌炎
- 批准号:
8576302 - 财政年份:2013
- 资助金额:
$ 3.08万 - 项目类别: